Gene: ZNF564
Official Full Name: zinc finger protein 564provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12157 | ZNF564 Knockout cell line (HeLa) | Human | ZNF564 | 1:3~1:6 | Negative | Online Inquiry |
KO12158 | ZNF564 Knockout cell line (HCT 116) | Human | ZNF564 | 1:2~1:4 | Negative | Online Inquiry |
KO12159 | ZNF564 Knockout cell line (HEK293) | Human | ZNF564 | 1:3~1:6 | Negative | Online Inquiry |
KO12160 | ZNF564 Knockout cell line (A549) | Human | ZNF564 | 1:3~1:4 | Negative | Online Inquiry |
ZNF564 Gene Knockout Cell Lines are genetically engineered cellular models specifically designed to study the function of the ZNF564 gene, which encodes a zinc finger protein integral to various cellular processes, including gene regulation, cellular differentiation, and response to stress. Utilizing advanced CRISPR-Cas9 technology, these cell lines provide a robust platform for elucidating the biological role of ZNF564, as well as its implications in different pathological states, including cancer.
The primary mechanism enabling the functionality of these cell lines involves the targeted disruption of the ZNF564 gene, which allows researchers to observe the resultant phenotypic changes, signaling pathways, and gene expression alterations. By modeling a complete knockout, scientists can investigate the gene's contributions to cellular homeostasis and explore the downstream effects of its loss, offering insights that are invaluable for both basic research and therapeutic investigations.
The scientific significance of ZNF564 Gene Knockout Cell Lines extends to multiple domains, including cancer research, developmental biology, and drug discovery. These cell lines enable researchers to dissect the intricate roles of ZNF564 in tumorigenesis and identify potential therapeutic targets, fostering advancements in personalized medicine. The specificity and reliability of these cell lines provide a distinct advantage over alternatives, such as temporary knockdown methods, which may not adequately represent the sustained biological consequences of gene loss.
Researchers and clinicians will find great value in the ZNF564 Gene Knockout Cell Lines, as they facilitate rigorous investigations into gene function and therapeutic interventions. The comprehensive nature of this product not only promotes reproducibility and consistency in experimental outcomes but also empowers the scientific community to push the boundaries of our understanding of gene dynamics.
With our company's extensive expertise in gene editing technologies and commitment to providing high-quality research tools, we ensure that our ZNF564 Gene Knockout Cell Lines are produced under stringent quality control standards, making them a reliable choice for cutting-edge research applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.